一项综合分析揭示了TP53I11在瘤微环境中的血管功能
Wen Bai1,2, Jun-Song Ren1,2, Ke-Ran Li1,2
1The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China.
Heliyon
|April 24, 2024
概括
瘤蛋白P53诱导蛋白11 (TP53I11) 在癌症中起着复杂的作用,在各种癌症类型中不同影响生存率. 这项研究将TP53I11与瘤血管生成和低氧条件下的HIF2A调节联系起来.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 瘤蛋白P53诱导蛋白11 (TP53I11) 在癌症进展中的确切功能尚未完全理解.
- 现有证据表明TP53I11在各种恶性瘤中起着重要但不清楚的作用.
研究的目的:
- 进行TP53I11表达的全面泛癌分析,其预后价值,以及其在瘤生物学中的功能作用.
- 阐明TP53I11调节背后的分子机制及其对血管生成的影响.
主要方法:
- 全癌症分析TP53I11表达和与多种癌症类型患者存活率的相关性.
- 研究TP53I11与DNA甲基化和翻译后修饰 (酸化) 的关联.
- 使用人类静脉内皮细胞 (HUVEC) 的体外血管生成测定和涉及HIF2A和缺氧的机制研究.
主要成果:
- 与正常组织相比,TP53I11的表达在瘤组织中具有显著的差异,具有差异性的预后影响 (对BRCA,KIRP,MESO,UVM有害;对KIRC有益).
- TP53I11表达与DNA甲基化有负相关性,并且在几种癌症类型中显示S14残留物的酸化.
- 在低氧条件下,TP53I11在体外促进血管生成,并在低氧条件下通过HIF2A进行转录上调,这表明它在瘤血管化中的作用.
结论:
- TP53I11在癌症中表现出上下文依赖的作用,影响患者的存活率和瘤进展.
- TP53I11涉及促进瘤血管生成,可能通过对低氧反应的HIF2A的调节.
- 对TP53I11的机制的进一步研究可能会揭示癌症治疗的新疗法策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


